<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02784990</url>
  </required_header>
  <id_info>
    <org_study_id>FACY PHRCI 2015</org_study_id>
    <nct_id>NCT02784990</nct_id>
  </id_info>
  <brief_title>Study of Pancreatic Enzymes in the Drains as Early Biomarkers of Post-operative Pancreatic Fistula and Its Clinical Repercussions</brief_title>
  <acronym>LIPA-DRAIN</acronym>
  <official_title>Study of Pancreatic Enzymes in the Drains as Early Biomarkers of Post-operative Pancreatic Fistula and Its Clinical Repercussions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <brief_summary>
    <textblock>
      Surgery is the principal treatment for benign and malignant pancreatic tumours. This surgery&#xD;
      can be accompanied by complications among which the main one is pancreatic fistula, which&#xD;
      leads to the flow of pancreatic juices into the abdominal cavity. Depending on its severity,&#xD;
      a fistula can be managed medically, with the implantation of a la pose d'un percutaneous&#xD;
      drain, endoscopic treatment, or revisit surgery. It has been shown that early management of&#xD;
      the fistula prevents it from evolving towards major complications such as haemorrhage or&#xD;
      serious intra-abdominal infections.&#xD;
&#xD;
      To date, the early diagnosis of pancreatic fistula is based on high levels of one pancreatic&#xD;
      enzyme, amylase, in the drains. However in certain clinical situations, patients present&#xD;
      post-operative fistulas with no elevation of amylase. And, on the contrary, increased amylase&#xD;
      with no clinical consequences.&#xD;
&#xD;
      It is therefore necessary to identify another early early marker of pancreatic fistula that&#xD;
      corresponds better to clinical signs.&#xD;
&#xD;
      In a preliminary study conducted in 65 patients, the investigators recently found that&#xD;
      another pancreatic enzyme (lipase) could be a more pertinent marker of pancreatic fistula,&#xD;
      but this requires confirmation in a greater number of patients.&#xD;
&#xD;
      The objective is to evaluate the diagnostic performance of lipase in the drains for the early&#xD;
      detection of pancreatic fistula with clinical repercussions in the 30 days following the&#xD;
      surgery.&#xD;
&#xD;
      The study consists in collecting at 4 different time points (D1, D3, D4 and D6) a tube of&#xD;
      blood and a tube of drain liquid.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 3, 2016</start_date>
  <completion_date type="Actual">November 3, 2020</completion_date>
  <primary_completion_date type="Actual">November 3, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Dosage of lipase in the drains</measure>
    <time_frame>3 days after surgical resection</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">770</enrollment>
  <condition>Pancreatic Fistula</condition>
  <arm_group>
    <arm_group_label>Patient</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Lipase, amylase and CRP (C-reactive protein) dosages</intervention_name>
    <arm_group_label>Patient</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing scheduled pancreatic resection&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients over 18&#xD;
&#xD;
          -  Patients undergoing scheduled pancreatic resection with or without anastomosis&#xD;
             (cephalic duodenopancreatectomy, median pancreatectomy, left pancreatectomy,&#xD;
             enucleation)&#xD;
&#xD;
          -  Patients able to understand instructions/information&#xD;
&#xD;
          -  Patients who have provided written informed consent&#xD;
&#xD;
          -  Patients with Health Insurance cover&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with scheduled total pancreatectomy&#xD;
&#xD;
          -  Adults under wardship&#xD;
&#xD;
          -  Pregnant or breast-feeding women&#xD;
&#xD;
          -  Total pancreatectomy&#xD;
&#xD;
          -  Pancreatectomy not feasible&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU Jean Minjoz</name>
      <address>
        <city>Besancon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU William MOREY</name>
      <address>
        <city>Chalon-sur-Saône</city>
        <zip>71321</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Dijon Bourgogne</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Grenoble Alpes</name>
      <address>
        <city>La Tronche</city>
        <zip>38700</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Claude Huriez</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HCL - Hôpital universitaire de la Croix Rousse</name>
      <address>
        <city>Lyon</city>
        <zip>69317</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>APHM - Institut Paoli-Calmettes</name>
      <address>
        <city>Marseille</city>
        <zip>13009</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de REIMS - Hôpital Robert Debré</name>
      <address>
        <city>Reims</city>
        <zip>51100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de NANCY</name>
      <address>
        <city>Vandoeuvre Les Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>May 18, 2016</study_first_submitted>
  <study_first_submitted_qc>May 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 27, 2016</study_first_posted>
  <last_update_submitted>March 9, 2021</last_update_submitted>
  <last_update_submitted_qc>March 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Fistula</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

